Anti-SYTL2/ CHR11SYT/ EXO4 monoclonal antibody

Anti-SYTL2/ CHR11SYT/ EXO4 antibody for FACS & in-vivo assay

Target products collectionGo to SYTL2/SYTL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2344-Ab-1/ GM-Tg-hg-MP2344-Ab-2Anti-Human SYTL2 monoclonal antibodyHuman
GM-Tg-rg-MP2344-Ab-1/ GM-Tg-rg-MP2344-Ab-2Anti-Rat SYTL2 monoclonal antibodyRat
GM-Tg-mg-MP2344-Ab-1/ GM-Tg-mg-MP2344-Ab-2Anti-Mouse SYTL2 monoclonal antibodyMouse
GM-Tg-cynog-MP2344-Ab-1/ GM-Tg-cynog-MP2344-Ab-2Anti-Cynomolgus/ Rhesus macaque SYTL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2344-Ab-1/ GM-Tg-felg-MP2344-Ab-2Anti-Feline SYTL2 monoclonal antibodyFeline
GM-Tg-cang-MP2344-Ab-1/ GM-Tg-cang-MP2344-Ab-2Anti-Canine SYTL2 monoclonal antibodyCanine
GM-Tg-bovg-MP2344-Ab-1/ GM-Tg-bovg-MP2344-Ab-2Anti-Bovine SYTL2 monoclonal antibodyBovine
GM-Tg-equg-MP2344-Ab-1/ GM-Tg-equg-MP2344-Ab-2Anti-Equine SYTL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2344-Ab-1/ GM-Tg-hg-MP2344-Ab-2; GM-Tg-rg-MP2344-Ab-1/ GM-Tg-rg-MP2344-Ab-2;
GM-Tg-mg-MP2344-Ab-1/ GM-Tg-mg-MP2344-Ab-2; GM-Tg-cynog-MP2344-Ab-1/ GM-Tg-cynog-MP2344-Ab-2;
GM-Tg-felg-MP2344-Ab-1/ GM-Tg-felg-MP2344-Ab-2; GM-Tg-cang-MP2344-Ab-1/ GM-Tg-cang-MP2344-Ab-2;
GM-Tg-bovg-MP2344-Ab-1/ GM-Tg-bovg-MP2344-Ab-2; GM-Tg-equg-MP2344-Ab-1/ GM-Tg-equg-MP2344-Ab-2
Products NameAnti-SYTL2 monoclonal antibody
Formatmab
Target NameSYTL2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SYTL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SYTL2/ CHR11SYT/ EXO4 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2344
    Target NameSYTL2
    Gene ID54843,83671,361604,703187,485154,101095914,614406,100050854
    Gene Symbol and SynonymsCHR11SYT,EXO4,mKIAA1597,PPP1R151,SGA72M,SLP2,SLP2A,SYTL2
    Uniprot AccessionQ9HCH5,A6QP06
    Uniprot Entry NameSYTL2_HUMAN,SYTL2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137501
    Target ClassificationN/A

    The target: SYTL2, gene name: SYTL2, also named as CHR11SYT, EXO4, PPP1R151, SGA72M, SLP2, SLP2A. The protein encoded by this gene is a synaptotagmin-like protein (SLP) that belongs to a C2 domain-containing protein family. The SLP homology domain (SHD) of this protein has been shown to specifically bind the GTP-bound form of Ras-related protein Rab-27A (RAB27A). This protein plays a role in RAB27A-dependent vesicle trafficking and controls melanosome distribution in the cell periphery. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.